About Epoch Biodesign
Epoch Biodesign is a company based in London (United Kingdom) founded in 2019 by Jacob Nathan.. Epoch Biodesign has raised $41.3 million across 4 funding rounds from investors including Gov.uk, Inditex and Lowercarbon. The company has 25 employees as of March 31, 2024. Epoch Biodesign offers products and services including Biorecycling Platform and AI-Designed Enzymes.
- Headquarter London, United Kingdom
- Employees 25 as on 31 Mar, 2024
- Founders Jacob Nathan
-
Sectors
Transportation, Automotive & Logistics
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Epoch Biodesign Ltd
- Date of Incorporation 13 Feb, 2019
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41.3 M (USD)
in 4 rounds
-
Latest Funding Round
$12 M (USD), Series A
Mar 24, 2026
-
Investors
Gov.uk
& 17 more
-
Employee Count
25
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epoch Biodesign
Epoch Biodesign offers a comprehensive portfolio of products and services, including Biorecycling Platform and AI-Designed Enzymes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-driven platform for infinite recycling of plastics and textiles.
Enzymes that enable low-temperature recycling for mixed materials.
Unlock access to complete
Funding Insights of Epoch Biodesign
Epoch Biodesign has successfully raised a total of $41.3M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $12.0M
-
First Round
First Round
(13 Jun 2022)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2026 | Amount | Series A - Epoch Biodesign | Valuation |
investors |
|
| Mar, 2025 | Amount | Grant - Epoch Biodesign | Valuation |
investors |
|
| Mar, 2025 | Amount | Series A - Epoch Biodesign | Valuation | Extantia |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Epoch Biodesign
Epoch Biodesign has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Inditex and Lowercarbon. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Extantia is focused on investing in climate technology pioneers.
|
Founded Year | Domain | Location | |
|
Early-stage investments are targeted globally by this VC fund.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Epoch Biodesign
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Epoch Biodesign
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epoch Biodesign Comparisons
Competitors of Epoch Biodesign
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epoch Biodesign
Frequently Asked Questions about Epoch Biodesign
When was Epoch Biodesign founded?
Epoch Biodesign was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Epoch Biodesign located?
Epoch Biodesign is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Epoch Biodesign?
Jacob Nathan is the current CEO of Epoch Biodesign. They have also founded this company.
Is Epoch Biodesign a funded company?
Epoch Biodesign is a funded company, having raised a total of $41.3M across 4 funding rounds to date. The company's 1st funding round was a Grant of $1M, raised on Jun 13, 2022.
How many employees does Epoch Biodesign have?
As of Mar 31, 2024, the latest employee count at Epoch Biodesign is 25.
What does Epoch Biodesign do?
Epoch Biodesign was founded in 2019 in London, United Kingdom. A biorecycling platform is operated by the company within the sustainability and materials science sector. Mixed plastics and textiles, including nylon and polyester, are processed using AI-designed enzymes for low-temperature recycling. Outputs are generated for applications in apparel, automotive, and packaging industries. Synthetic biology, process engineering, and AI are integrated to manage waste streams effectively.
What products or services does Epoch Biodesign offer?
Epoch Biodesign offers Biorecycling Platform and AI-Designed Enzymes.
Who are Epoch Biodesign's investors?
Epoch Biodesign has 18 investors. Key investors include Gov.uk, Inditex, Lowercarbon, Voyagers, and Extantia.